All In Biotech

Drug Trial Radar · NCT05175001

Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Thoracic Paravertebral Nerve Block for Chronic Post-thoracotomy Pain

Last checked: Nov 19, 2026Latest source record: Mar 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

May 1, 2021

Primary completion

Jun 30, 2022

Study completion Jan 30, 2023

Sponsor

Lead sponsor
Affiliated Hospital of Nantong UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 3, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Chronic post-thoracotomy pain(CPTP)will not only have a negative impact on patients' physiology and psychology, but also affect postoperative recovery.A number of researches have demonstrated that Injury to the intercostal nerve during surgery predominantly accounts for the onset of CPTP.It is closely related to postoperative local acute inflammation and neuroinflammation. Thoracic paravertebral block (TPVB)has become a new trend for post-thoracotomy pain management.Glucocorticoids,as a adjuvant, are reported to prolong the effects of local anesthetic for peripheral nerve blocks.Diprospan is a long-acting glucocorticoid. It has been widely used in clinical treatment of various pain syndromes for powerful analgesic and anti-inflammatory effects. At present, most clinical reports are limited to the acute postoperative period, and there are few studies focusing on the long-term postoperative analgesic effect of diprospan.Therefore, it is reasonable for us to hypothesise diprospan, as a longer-acting glucocorticoid, can provide more lasting analgesic effects,or even reduce the incidence of CPTP

Conditions

  • Chronic Pain

Interventions

  • DiprospanDrug

    Diprospan combined with ropivacaine in ultrasound-guided thoracic paravertebral nerve block

  • RopivacaineDrug

    Only ropivacaine in ultrasound-guided thoracic paravertebral nerve block

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Acute and chronic postoperative painTime frame: 24 hours after surgery
  2. Acute and chronic postoperative painTime frame: 48 hours after surgery
  3. Acute and chronic postoperative painTime frame: 72 hours after surgery
  4. Acute and chronic postoperative painTime frame: 1 month after surgery
  5. Acute and chronic postoperative painTime frame: 3 months after surgery
  6. Acute and chronic postoperative painTime frame: 6 months after surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Affiliated Hospital of Nantong University

    Nantong, Jiangsu, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.